United States (US) COVID-19 Saliva Screening Test Potential Market (2025-2031) | Industry, Companies, Growth, Trends, Share, Outlook, Competitive Landscape, Size & Revenue, Analysis, Value, Forecast, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) COVID-19 Saliva Screening Test Potential Market - Industry Life Cycle

3.4 United States (US) COVID-19 Saliva Screening Test Potential Market - Porter's Five Forces

3.5 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Location, 2021 & 2031F

3.6 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Mode, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for non-invasive and easy-to-administer testing methods due to the convenience and comfort of saliva-based tests.

4.2.2 Government initiatives and funding to support widespread COVID-19 testing, including saliva screening tests, to control the spread of the virus.

4.2.3 Growing awareness and acceptance of saliva-based testing among the population, leading to higher adoption rates.

4.3 Market Restraints

4.3.1 Regulatory challenges and approvals required for saliva-based COVID-19 screening tests may delay market entry and implementation.

4.3.2 Quality control and accuracy concerns associated with saliva tests compared to traditional nasal swab tests may hinder widespread adoption.

6.1 United States (US) COVID-19 Saliva Screening Test Potential Market, By Location

6.1.1 Overview and Analysis

6.1.2 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Location, 2021- 2031F

6.1.3 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Travel Stations, 2021- 2031F

6.1.4 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Sports Arenas, 2021- 2031F

6.1.5 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Entertainment Venues, 2021- 2031F

6.1.6 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Corporate Campus Environments, 2021- 2031F

6.1.7 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Universities & Colleges, 2021- 2031F

6.1.8 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Factories, 2021- 2031F

6.2 United States (US) COVID-19 Saliva Screening Test Potential Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Fluorescence-labeled antigen/antibodies testing, 2021- 2031F

6.2.3 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By RT-PCR, 2021- 2031F

6.2.4 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By CRISPR-Cas9, 2021- 2031F

6.3 United States (US) COVID-19 Saliva Screening Test Potential Market, By Mode

6.3.1 Overview and Analysis

6.3.2 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Centralized Testing, 2021- 2031F

6.3.3 United States (US) COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Decentralized Testing, 2021- 2031F

7.1 United States (US) COVID-19 Saliva Screening Test Potential Market Export to Major Countries

7.2 United States (US) COVID-19 Saliva Screening Test Potential Market Imports from Major Countries

8.1 Turnaround time for test results, as faster results can lead to increased adoption and utilization of saliva-based COVID-19 screening tests.

8.2 Percentage of population tested using saliva-based tests, indicating the penetration and acceptance of this testing method.

8.3 Research and development investment in improving the sensitivity and specificity of saliva-based testing kits, to ensure their reliability and accuracy.

9.1 United States (US) COVID-19 Saliva Screening Test Potential Market Opportunity Assessment, By Location, 2021 & 2031F

9.2 United States (US) COVID-19 Saliva Screening Test Potential Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) COVID-19 Saliva Screening Test Potential Market Opportunity Assessment, By Mode, 2021 & 2031F

10.1 United States (US) COVID-19 Saliva Screening Test Potential Market Revenue Share, By Companies, 2024

10.2 United States (US) COVID-19 Saliva Screening Test Potential Market Competitive Benchmarking, By Operating and Technical Parameters